Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
暂无分享,去创建一个
B. Julian | J. Novak | Y. Tomino | L. Thibaudin | F. Berthoux | Hitoshi Suzuki | N. Maillard | C. Mariat | Hiroyuki Yanagawa | H. Suzuki
[1] R. Camilla,et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. , 2010, Kidney international.
[2] J. Barratt,et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. , 2001, Kidney international.
[3] B. Julian,et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. , 1997, Kidney international.
[4] Yusuke Suzuki,et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. , 2009, The Journal of clinical investigation.
[5] Y. Hiki,et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. , 1999, Journal of the American Society of Nephrology : JASN.
[6] J. Berger. IgA glomerular deposits in renal disease. , 1969, Transplantation proceedings.
[7] B. Julian,et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. , 2005, Kidney international.
[8] B. Julian,et al. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[9] S. Harper,et al. Galactosylation of N‐ and O‐linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy , 1995, Clinical and experimental immunology.
[10] Y. Hiki,et al. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry. , 2010, Journal of nephrology.
[11] B. Julian,et al. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[12] H. Cooper,et al. Determination of Aberrant O-Glycosylation in the IgA1 Hinge Region by Electron Capture Dissociation Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry* , 2005, Journal of Biological Chemistry.
[13] B. Julian,et al. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. , 2010, Biochemistry.
[14] A. Michael,et al. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. , 1980, The Journal of clinical investigation.
[15] J. Berger,et al. Intercapillary deposits of IgA-IgC. , 2000, Journal of the American Society of Nephrology : JASN.
[16] S. Bellur,et al. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] J. Barratt,et al. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. , 1999, Journal of the American Society of Nephrology : JASN.
[18] J. Berger,et al. [Intercapillary deposits of IgA-IgG]. , 1968, Journal d'urologie et de nephrologie.
[19] R. Lifton,et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.
[20] Y. Hiki,et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 1998, Journal of the American Society of Nephrology : JASN.
[21] Jonathan Barratt,et al. An update on the pathogenesis and treatment of IgA nephropathy. , 2012, Kidney international.
[22] Michael J Pencina,et al. Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality , 2011, Statistics in medicine.
[23] L. Thibaudin,et al. Predicting the risk for dialysis or death in IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[24] Y. Hiki,et al. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] F. Berthoux,et al. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. , 1991, American Journal of Kidney Diseases.
[26] B. Julian,et al. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. , 2007, Molecular immunology.
[27] B. Julian,et al. The pathophysiology of IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[28] Michael J Pencina,et al. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models , 2012, Statistics in medicine.
[29] B. Julian,et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. , 2011, Kidney international.
[30] G. Alarcón,et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. , 2008, The Journal of clinical investigation.
[31] F. Berthoux,et al. Natural history of primary IgA nephropathy. , 2008, Seminars in nephrology.
[32] B. Julian,et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. , 1999, The Journal of clinical investigation.
[33] Y. Hiki,et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. , 2001, Kidney international.
[34] B. Julian,et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. , 2007, Kidney international.
[35] Hong Zhang,et al. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] B. Julian,et al. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] B. Julian,et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. , 2008, Seminars in nephrology.